Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from Omikron Italia S.r.l., submitted pursuant to Article 13.5 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health cla...

Full description

Bibliographic Details
Main Author: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:EFSA Journal
Subjects:
Online Access:http://www.efsa.europa.eu/en/efsajournal/doc/3511.pdf
_version_ 1818617004572016640
author EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
author_facet EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
author_sort EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
collection DOAJ
description Following an application from Omikron Italia S.r.l., submitted pursuant to Article 13.5 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability. The food that is a subject of the health claim, a combination of diosmin, troxerutin and hesperidin, is sufficiently characterised. The claimed effect, maintenance of normal venous-capillary permeability, is a beneficial physiological effect. No human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of diosmin, troxerutin and hesperidin and the maintenance of normal venous-capillary permeability.
first_indexed 2024-12-16T16:58:48Z
format Article
id doaj.art-60c0e70bbf0f404ca0c3ff172aee8d56
institution Directory Open Access Journal
issn 1831-4732
language English
last_indexed 2024-12-16T16:58:48Z
publishDate 2014-01-01
publisher Wiley
record_format Article
series EFSA Journal
spelling doaj.art-60c0e70bbf0f404ca0c3ff172aee8d562022-12-21T22:23:49ZengWileyEFSA Journal1831-47322014-01-0112110.2903/j.efsa.2014.3511EFSA Journal 2014;12(1):3511Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Following an application from Omikron Italia S.r.l., submitted pursuant to Article 13.5 of Regulation (EC) No 1924/2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability. The food that is a subject of the health claim, a combination of diosmin, troxerutin and hesperidin, is sufficiently characterised. The claimed effect, maintenance of normal venous-capillary permeability, is a beneficial physiological effect. No human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of diosmin, troxerutin and hesperidin and the maintenance of normal venous-capillary permeability.http://www.efsa.europa.eu/en/efsajournal/doc/3511.pdfdiosmintroxerutinhesperidinvenous permeabilityhealth claims
spellingShingle EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006
EFSA Journal
diosmin
troxerutin
hesperidin
venous permeability
health claims
title Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_full Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_fullStr Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_full_unstemmed Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_short Scientific Opinion on the substantiation of a health claim related to a combination of diosmin, troxerutin and hesperidin and maintenance of normal venous-capillary permeability pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_sort scientific opinion on the substantiation of a health claim related to a combination of diosmin troxerutin and hesperidin and maintenance of normal venous capillary permeability pursuant to article 13 5 of regulation ec no 1924 2006
topic diosmin
troxerutin
hesperidin
venous permeability
health claims
url http://www.efsa.europa.eu/en/efsajournal/doc/3511.pdf
work_keys_str_mv AT efsapanelondieteticproductsnutritionandallergiesnda scientificopiniononthesubstantiationofahealthclaimrelatedtoacombinationofdiosmintroxerutinandhesperidinandmaintenanceofnormalvenouscapillarypermeabilitypursuanttoarticle135ofregulationecno19242006